10x Genomics Inc (NAS:TXG)
$ 24.34 -0.49 (-1.97%) Market Cap: 2.91 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 4.05 GF Score: 75/100

10X Genomics Inc Investor Day Transcript

Dec 08, 2022 / 05:00PM GMT
Release Date Price: $36.75 (+7.27%)
Cassie Corneau
10x Genomics, Inc. - Manager of IR and Strategic Finance

Hi, everyone, and welcome to the 10x Genomics 2022 Investor Day. We're so excited for what we have in store for you today. To everyone here in the room and everyone on the webcast, thank you for joining us. For those of you I haven't met, my name is Cassie Corneau, and I'm the Head of Investor Relations and Strategic Finance here at 10x. While I joined 10x a little over 2 years ago, I was first introduced to the team almost 4 years ago while working on the company's IPO. It was through that process that I first got to experience how different 10x is.

The company has evolved a tremendous amount since that time. but that differentiation in our innovation, our people and our scale is still at the heart of 10x today. We've built our event today to showcase this. Serge is going to kick off the day. There's no 1 better to outline the mission and vision of the company, discuss the opportunity ahead and show you how we're just getting started. Then you'll hear from Ben and Mike who will walk you through the 10x innovation engine and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot